Activation of the cyclin D1 promoter by arsenite
亚砷酸盐激活细胞周期蛋白 D1 启动子
基本信息
- 批准号:7896859
- 负责人:
- 金额:$ 11.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesArsenicArsenitesBindingBiological AssayBiological ModelsBurn injuryCREB1 geneCancer EtiologyCarcinogensCell CycleCell Cycle RegulationChemicalsChemosensitizationCyclin D1CyclinsDevelopmentDominant-Negative MutationElectrophoretic Mobility Shift AssayElementsEnvironmental PollutantsEventExposure toFundingFutureGenetic TranscriptionGlobal ChangeGoalsHealthHumanIndividualLightLuciferasesMAP Kinase ModulesMAPK14 geneMAPK8 geneMalignant NeoplasmsMeasuresMitogen-Activated Protein KinasesMolecularOncogenicPathway interactionsPatternPhosphorylationPopulations at RiskPreventionProcessProteinsPublic HealthRNAReactive Oxygen SpeciesReporterResearchRoleSignal PathwaySkinSolar EnergyStagingStressSystemTestingTimeTranscription Factor AP-1Transcriptional RegulationUp-RegulationWestern BlottingWorkWritingbasecarcinogenesischromatin immunoprecipitationin vitro Modelin vivoinhibitor/antagonistinsightkeratinocytemutantnovelnovel strategiesoverexpressionpromoterpublic health relevanceresearch studyresponsetranscription factortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): In the previous funding period we showed that treatment of cultured human keratinocytes with arsenite at submicromolar concentrations induced expression of cyclin D1 and this was accompanied by a shift into the G2 compartment of the cell cycle. Electrophoretic mobility shift assays (EMSA) demonstrated enhanced binding of AP1 and CREB transcription factors to their cognate binding motifs in the cyclin D1 promoter Here we wish to continue the work begun in the previous SCORE funding period by, a) using promoter deletion mutants in luciferase reporter assays to study transcriptional activity and, b) by using chromatin immunoprecipitation (ChIP) as an in vivo assay of transcriptional control of cyclin D1 expression by arsenite. We hypothesize that arsenite is an effector of the MAP kinase stress activated pathway which ultimately activates JNK. To test this we will examine the MAP kinase components of the ERK, JNK and p38 pathways in more detail by using a) chemical inhibitors of components of the MAP kinase pathways and b) dominant negative mutants. Activation of transcription factors resulting from phosphorylation will be demonstrated by western blotting using phosphorylation-specific antibodies. Although our main focus will be on the known components of signaling pathways the possibility exists that arsenite may also bring about phosphorylation of novel elements that may act further upstream. For this reason we also want to examine more global changes in patterns of phosphorylation that occur in response to arsenite using antibody microarrays with a view towards discerning changes in patterns of phosphorylation of proteins that is correlated with the induction of cyclin D1 via transcription factor activation. Finally, we wish to explore the possibility that the inductive effects of arsenite are related to reactive oxygen species as preliminary evidence indicates. If this can be demonstrated this finding will form the basis for future research.
PUBLIC HEALTH RELEVANCE: Arsenic is a toxic environmental pollutant and carcinogen. The experiments described are intended to shed light on the molecular mechanism by which arsenic causes cancer in individuals exposed to arsenic over long periods of time. This will ultimately provide targets that may form the basis for new approaches for the prevention of arsenic-caused cancers.
描述(由申请人提供):在上一个资金期间,我们表明在亚摩尔摩尔浓度下用砷的培养的人角质形成细胞诱导了Cyclin d1的表达,这伴随着转移到细胞周期的G2室的转移。电泳迁移率转移测定法(EMSA)表明,AP1和CREB转录因子的结合增强了其与它们在Cyclin d1启动子中的相关结合基序的结合,我们希望继续在上一个得分资金中开始的工作开始,a)通过使用Luciferase reptrip Anditor contriptions Andive and chromatition Andemation(a)通过研究转录术的chromation contriptiation(b),并通过研究(b)进行转录式(b),并通过chrip chromatition(b)进行转录式(B),并通过chromate contriptions(b)进行转录式(b)。通过砷对细胞周期蛋白D1表达的转录控制的测定。我们假设砷是MAP激酶应力激活途径的效应子,该途径最终激活JNK。为了测试这一点,我们将通过使用a)MAP激酶途径和b)显性阴性突变体的MAP激酶途径成分的化学抑制剂来更详细地研究ERK,JNK和P38途径的MAP激酶成分。磷酸化引起的转录因子的激活将通过使用磷酸化特异性抗体的蛋白质印迹来证明。尽管我们的主要重点将放在信号通路的已知组成部分上,但存在砷也可能引起可能在上游进一步起作用的新元素的磷酸化的可能性。因此,我们还希望检查使用抗体微阵列响应磷酸化模式的更多全球变化,以鉴定蛋白质磷酸化模式的变化,而蛋白质的磷酸化模式与通过转录因子激活诱导的细胞周期蛋白D1相关。最后,我们希望探讨砷的归纳作用与初步证据所表明的那样,砷的感应作用与活性氧有关。如果可以证明这一点,这一发现将构成未来研究的基础。
公共卫生相关性:砷是一种有毒的环境污染物和致癌物。所描述的实验旨在阐明分子机制,该机制在长时间内暴露于砷的个体中引起砷的癌症。这最终将提供目标,这可能是预防砷引起的癌症的新方法的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK L STEINBERG其他文献
MARK L STEINBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK L STEINBERG', 18)}}的其他基金
Activation of the cyclin D1 promoter by arsenite
亚砷酸盐激活细胞周期蛋白 D1 启动子
- 批准号:
8288735 - 财政年份:2009
- 资助金额:
$ 11.55万 - 项目类别:
Activation of the cyclin D1 promoter by arsenite
亚砷酸盐激活细胞周期蛋白 D1 启动子
- 批准号:
7693131 - 财政年份:2009
- 资助金额:
$ 11.55万 - 项目类别:
Activation of the cyclin D1 promoter by arsenite
亚砷酸盐激活细胞周期蛋白 D1 启动子
- 批准号:
8098102 - 财政年份:2009
- 资助金额:
$ 11.55万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
EPIGENETIC MECHANISMS AS FETAL BASIS OF TRANSPLACENTAL ARSENIC CARCINOGENISIS
作为经胎盘砷致癌胎儿基础的表观遗传机制
- 批准号:
8360690 - 财政年份:2011
- 资助金额:
$ 11.55万 - 项目类别: